Cervical Cancer Screening
67
17
19
24
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 67 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
21%
5 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 24 completed trials
Clinical Trials (67)
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT
Mail-in HPV Screening Program in NJ
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (Phase 2)
Introducing a Telemedicine Strategy to Deliver Cervical Cancer Screening Results in El Salvador
Social Media-Based Education on Cancer Screening Awareness in Women: A Randomized Controlled Trial
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Community Gateway to Health Study
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana
Developing and Implementing HPV SCREENED
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
A Mobile Web App Intervention to Promote Cervical Cancer Screening
Education and Health in Women With Cervical Cancer
Emergency Department-based Cervical Cancer Screening Through Self-sampling
The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
Cancer Awareness Among Syrian Migrants
HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy
Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Community Implementation of Urine HPV Test and Reflex DNA Methylation Test in Cervical Cancer Screening